Skip to content

Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone

Randomized Double Blind Comparison of Applied Behavioral Analysis Versus ABA and Risperidone

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00374764
Enrollment
60
Registered
2006-09-11
Start date
2000-07-31
Completion date
2002-06-30
Last updated
2007-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autistic Disorder

Keywords

Autism, Applied Behavioral Analysis, Risperidone

Brief summary

Hypotheses: 1. Preschool children with autism spectrum disorders (ASDs) who undergo ABA treatment only will demonstrate significantly better outcomes compared to an age and severity matched control group without ABA treatment. 2. Preschool children with ASDs who undergo ABA in combination with risperidone will demonstrate significantly better outcomes compared to age and severity matched children who are receiving ABA alone. 3. Young age, cognitive development and attentional abilities at baseline will be predictive of good socio-emotional and neuropsychological outcomes after ABA treatment. 4. At baseline, children with ASDs will show significantly lower performances on measures of cognitive, neuropsychological, and socio-emotional functioning than age-matched typically developing controls.

Interventions

DRUGRisperidone
BEHAVIORALABA

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
30 Months to 5 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosis of autism or severe pervasive developmental disorder (PDD) not otherwise specified (NOS) according to the Autism Diagnosis Interview-Revised (ADI-R) * Aged 2.6 to 5.0.

Exclusion criteria

* Fragile X or metabolic etiology of PDD symptoms * Diagnosis of other central nervous system (CNS) disorders * Chronic serious medical problems

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026